More recently, bradykinin has been demonstrated to promote the migration and invasion of human hepatocellular carcinoma cells by upregulating the expression of TRPM7 and facilitating the secretion of matrix metalloproteinase 2 (MMP2). The gene discussed is MMP2; the disease is hepatocellular carcinoma.